Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Autor: Michelson, David, Snyder, Ellen, Paradis, Erin, Chengan-Liu, Mary, Snavely, Duane B, Hutzelmann, Jill, Walsh, James K, Krystal, Andrew D, Benca, Ruth M, Cohn, Martin, Lines, Christopher, Roth, Thomas, Herring, W Joseph
Zdroj: In Lancet Neurology May 2014 13(5):461-471
Databáze: ScienceDirect